rs8066940
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020649.3(CBX8):c.*1813C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.412 in 151,966 control chromosomes in the GnomAD database, including 14,542 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 14541 hom., cov: 30)
Exomes 𝑓: 0.33 ( 1 hom. )
Consequence
CBX8
NM_020649.3 3_prime_UTR
NM_020649.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.381
Publications
4 publications found
Genes affected
CBX8 (HGNC:15962): (chromobox 8) Enables methylated histone binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in chromatin and nucleoplasm. Part of PRC1 complex. Biomarker of esophagus squamous cell carcinoma and glioblastoma. [provided by Alliance of Genome Resources, Apr 2022]
CBX8 Gene-Disease associations (from GenCC):
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.632 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.412 AC: 62560AN: 151844Hom.: 14490 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
62560
AN:
151844
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.333 AC: 2AN: 6Hom.: 1 Cov.: 0 AF XY: 0.500 AC XY: 2AN XY: 4 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
6
Hom.:
Cov.:
0
AF XY:
AC XY:
2
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
2
AN:
6
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.412 AC: 62663AN: 151960Hom.: 14541 Cov.: 30 AF XY: 0.409 AC XY: 30339AN XY: 74266 show subpopulations
GnomAD4 genome
AF:
AC:
62663
AN:
151960
Hom.:
Cov.:
30
AF XY:
AC XY:
30339
AN XY:
74266
show subpopulations
African (AFR)
AF:
AC:
26420
AN:
41414
American (AMR)
AF:
AC:
4687
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1219
AN:
3472
East Asian (EAS)
AF:
AC:
1050
AN:
5146
South Asian (SAS)
AF:
AC:
2258
AN:
4814
European-Finnish (FIN)
AF:
AC:
2971
AN:
10554
Middle Eastern (MID)
AF:
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22922
AN:
67958
Other (OTH)
AF:
AC:
801
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1724
3448
5172
6896
8620
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1304
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.